<p>根據 Fifth Third Bancorp 最近向證券交易委員會提交的 13F 表格，該公司在第一季度將其在 CVS Health Co.（紐約證券交易所代碼：CVS - 免費報告）的持股增加了 4.6%。這家機構投資者在該季度購買了額外的 7,410 股後，持有 169,749 股該藥房運營商的股票。Fifth Third Bancorp 在 CVS Health 的持股在最近一個季度末的價值為 11,500,000 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
<p>其他對沖基金也對該公司的持倉進行了調整。挪威銀行在第四季度購買了價值約 839,574,000 美元的 CVS Health 新股份。Capital World Investors 在第四季度將其在 CVS Health 的持倉提高了 26.6%。Capital World Investors 現在擁有 61,039,777 股該藥房運營商的股票，價值為 2,739,927,000 美元，此前在上個季度又收購了 12,819,148 股。Davis Selected Advisers 在第四季度將其在 CVS Health 的持倉增加了 2,998.1%。Davis Selected Advisers 現在擁有 11,385,950 股該藥房運營商的股票，價值為 511,115,000 美元，此前在上個季度又購買了 11,018,438 股。Dodge &amp; Cox 在第四季度將其在 CVS Health 的持倉增加了 11.2%。Dodge &amp; Cox 現在擁有 70,105,899 股該藥房運營商的股票，價值為 3,147,054,000 美元，此前在上個季度又購買了 7,075,209 股。最後，Pzena Investment Management LLC 在第四季度將其在 CVS Health 的持倉增加了 49.3%。Pzena Investment Management LLC 現在擁有 19,610,579 股該藥房運營商的股票，價值為 880,319,000 美元，此前在上個季度又購買了 6,475,271 股。對沖基金和其他機構投資者持有該公司 80.66% 的股票。</p>
<h2>CVS Health 的內部交易</h2>
<p>在 CVS Health 的其他消息中，董事 Guy P. Sansone 在 6 月 5 日（星期四）購買了 1,570 股該公司的股票。該股票的平均購買價格為每股 63.70 美元，總交易額為 100,009.00 美元。購買後，該董事現在直接持有 12,007 股公司股票，價值為 764,845.90 美元。這筆交易代表了他們持股的 15.04% 的增長。該收購已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。目前，企業內部人士持有 1.22% 的股票。</p>
<h2>CVS Health 股票上漲 1.6%</h2>
<ul>
<li>現在是購買 Novo Nordisk 股票的好時機嗎？</li>
</ul>
<p>CVS Health 股票在週五開盤價為 67.42 美元。該股票的 50 日移動平均線為 65.15 美元，200 日移動平均線為 60.15 美元。該公司的市值為 852.9 億美元，市盈率為 18.42，市盈增長比率為 0.98，貝塔值為 0.56。該公司的速動比率為 0.60，流動比率為 0.81，債務股本比率為 0.80。CVS Health Co.的 12 個月低點為 43.56 美元，12 個月高點為 72.51 美元。</p>
<p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）最近在 5 月 1 日（星期四）公佈了其財報。該藥房運營商報告的每股收益（EPS）為 2.25 美元，超出分析師一致預期的 1.62 美元，超出幅度為 0.63 美元。該公司在本季度的收入為 945.9 億美元，而分析師預期為 930.7 億美元。CVS Health 的股本回報率為 9.11%，淨利潤率為 1.24%。與去年同期相比，CVS Health 本季度的收入增長了 7.0%。在去年同期，該公司每股收益為 1.31 美元。股票分析師預計 CVS Health Co.今年的每股收益將達到 5.89 美元。</p>
<h2>CVS Health 分紅公告</h2>
<ul>
<li>在 Eli Lilly 財報疲軟和 CVS-Novo 合作後，Eli Lilly 值得購買嗎？</li>
</ul>
<p>該公司還最近宣佈了季度分紅，分紅於 5 月 1 日（星期四）支付。4 月 22 日（星期二）登記在冊的股東獲得了 0.665 美元的分紅。這代表着每年 2.66 美元的分紅和 3.95% 的收益率。該分紅的除息日為 4 月 22 日（星期二）。CVS Health 的派息比率目前為 63.48%。</p>
<h2>華爾街分析師預測增長</h2>
<p>CVS 一直是多份研究分析報告的主題。摩根士丹利在 4 月 15 日（星期二）的報告中重申了對 CVS Health 股票的 “增持” 評級。Wall Street Zen 在 5 月 9 日（星期五）的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。Cowen 在 5 月 5 日（星期一）的研究報告中重申了對 CVS Health 股票的 “買入” 評級。Argus 在 2 月 18 日（星期二）的研究報告中設定了 CVS Health 的目標價為 77.00 美元。最後，Piper Sandler 在 3 月 21 日（星期五）的研究報告中將 CVS Health 的目標價從 72.00 美元上調至 74.00 美元，並給予該股票 “增持” 評級。有兩位研究分析師對該股票給予了 “持有” 評級，十七位給予了 “買入” 評級，一位給予了 “強烈買入” 評級。根據 MarketBeat，該股票的共識評級為 “適度買入”，共識目標價為 74.75 美元。</p>
<p><strong>查看我們關於 CVS 的最新報告</strong></p>
<h2>CVS Health 公司簡介</h2>
<p>（免費報告）</p>
<p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房及消費者健康三個部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票超過 CVS Health</li>
<li>什麼是國債？</li>
<li>IBM 連續上漲 10 天：是什麼推動了這一勝利的連勝？</li>
<li>什麼是分紅收割策略，投資者如何從中獲利？</li>
<li>Upstart 股票的牛市案例剛剛變得更強大</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>海灣石油產量增加使這些能源公司受到關注</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒是由敍事科學技術和 MarketBeat 的金融數據生成的，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
<p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 CVS Health 並不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

西維斯

五三銀行

<p>五三銀行在第一季度將其在 CVS Health Co.（紐約證券交易所代碼：CVS）的持股比例提高了 4.6%，目前持有 169,749 股，價值 1150 萬美元。其他機構投資者也調整了他們的持倉，其中挪威銀行和資本世界投資者的增持幅度顯著。CVS Health 的股票開盤價為 67.42 美元，市值為 852.9 億美元。該公司報告第一季度每股收益為 2.25 美元，超出預期，並宣佈季度股息為 0.665 美元。分析師們對其前景持積極態度，多家機構上調了評級，目標價為 77.00 美元</p>

<p>Fifth Third Bancorp grew its position in CVS Health Co. (NYSE:CVS - Free Report) by 4.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 169,749 shares of the pharmacy operator's stock after buying an additional 7,410 shares during the quarter. Fifth Third Bancorp's holdings in CVS Health were worth $11,500,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>根據 Fifth Third Bancorp 最近向證券交易委員會提交的 13F 表格，該公司在第一季度將其在 CVS Health Co.（紐約證券交易所代碼：CVS - 免費報告）的持股增加了 4.6%。這家機構投資者在該季度購買了額外的 7,410 股後，持有 169,749 股該藥房運營商的股票。Fifth Third Bancorp 在 CVS Health 的持股在最近一個季度末的價值為 11,500,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
</div><p>Other hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in CVS Health in the 4th quarter valued at about $839,574,000. Capital World Investors lifted its position in CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after acquiring an additional 12,819,148 shares in the last quarter. Davis Selected Advisers increased its holdings in CVS Health by 2,998.1% during the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock worth $511,115,000 after purchasing an additional 11,018,438 shares during the last quarter. Dodge &amp; Cox increased its holdings in CVS Health by 11.2% during the 4th quarter. Dodge &amp; Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after purchasing an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC increased its holdings in CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他對沖基金也對該公司的持倉進行了調整。挪威銀行在第四季度購買了價值約 839,574,000 美元的 CVS Health 新股份。Capital World Investors 在第四季度將其在 CVS Health 的持倉提高了 26.6%。Capital World Investors 現在擁有 61,039,777 股該藥房運營商的股票，價值為 2,739,927,000 美元，此前在上個季度又收購了 12,819,148 股。Davis Selected Advisers 在第四季度將其在 CVS Health 的持倉增加了 2,998.1%。Davis Selected Advisers 現在擁有 11,385,950 股該藥房運營商的股票，價值為 511,115,000 美元，此前在上個季度又購買了 11,018,438 股。Dodge &amp; Cox 在第四季度將其在 CVS Health 的持倉增加了 11.2%。Dodge &amp; Cox 現在擁有 70,105,899 股該藥房運營商的股票，價值為 3,147,054,000 美元，此前在上個季度又購買了 7,075,209 股。最後，Pzena Investment Management LLC 在第四季度將其在 CVS Health 的持倉增加了 49.3%。Pzena Investment Management LLC 現在擁有 19,610,579 股該藥房運營商的股票，價值為 880,319,000 美元，此前在上個季度又購買了 6,475,271 股。對沖基金和其他機構投資者持有該公司 80.66% 的股票。</p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的內部交易</h2>
</div><p>In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this link. 1.22% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在 CVS Health 的其他消息中，董事 Guy P. Sansone 在 6 月 5 日（星期四）購買了 1,570 股該公司的股票。該股票的平均購買價格為每股 63.70 美元，總交易額為 100,009.00 美元。購買後，該董事現在直接持有 12,007 股公司股票，價值為 764,845.90 美元。這筆交易代表了他們持股的 15.04% 的增長。該收購已在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。目前，企業內部人士持有 1.22% 的股票。</p>
</div><h2>CVS Health Stock Up 1.6%</h2>
<div class="lb-trans"><h2>CVS Health 股票上漲 1.6%</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>現在是購買 Novo Nordisk 股票的好時機嗎？</li>
</ul>
</div><p>Shares of CVS Health stock opened at $67.42 on Friday. The stock's fifty day moving average is $65.15 and its 200-day moving average is $60.15. The firm has a market capitalization of $85.29 billion, a PE ratio of 18.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51.</p>
<div class="lb-trans"><p>CVS Health 股票在週五開盤價為 67.42 美元。該股票的 50 日移動平均線為 65.15 美元，200 日移動平均線為 60.15 美元。該公司的市值為 852.9 億美元，市盈率為 18.42，市盈增長比率為 0.98，貝塔值為 0.56。該公司的速動比率為 0.60，流動比率為 0.81，債務股本比率為 0.80。CVS Health Co.的 12 個月低點為 43.56 美元，12 個月高點為 72.51 美元。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. CVS Health's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 earnings per share. Equities analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.</p>
<div class="lb-trans"><p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）最近在 5 月 1 日（星期四）公佈了其財報。該藥房運營商報告的每股收益（EPS）為 2.25 美元，超出分析師一致預期的 1.62 美元，超出幅度為 0.63 美元。該公司在本季度的收入為 945.9 億美元，而分析師預期為 930.7 億美元。CVS Health 的股本回報率為 9.11%，淨利潤率為 1.24%。與去年同期相比，CVS Health 本季度的收入增長了 7.0%。在去年同期，該公司每股收益為 1.31 美元。股票分析師預計 CVS Health Co.今年的每股收益將達到 5.89 美元。</p>
</div><h2>CVS Health Dividend Announcement</h2>
<div class="lb-trans"><h2>CVS Health 分紅公告</h2>
</div><ul>
<li>Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?</li>
</ul>
<div class="lb-trans"><ul>
<li>在 Eli Lilly 財報疲軟和 CVS-Novo 合作後，Eli Lilly 值得購買嗎？</li>
</ul>
</div><p>The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.95%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's payout ratio is currently 63.48%.</p>
<div class="lb-trans"><p>該公司還最近宣佈了季度分紅，分紅於 5 月 1 日（星期四）支付。4 月 22 日（星期二）登記在冊的股東獲得了 0.665 美元的分紅。這代表着每年 2.66 美元的分紅和 3.95% 的收益率。該分紅的除息日為 4 月 22 日（星期二）。CVS Health 的派息比率目前為 63.48%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>CVS has been the subject of a number of research analyst reports. Morgan Stanley reiterated an &#34;overweight&#34; rating on shares of CVS Health in a report on Tuesday, April 15th. Wall Street Zen upgraded CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Friday, May 9th. Cowen reiterated a &#34;buy&#34; rating on shares of CVS Health in a research report on Monday, May 5th. Argus set a $77.00 price target on CVS Health in a research report on Tuesday, February 18th. Finally, Piper Sandler boosted their price target on CVS Health from $72.00 to $74.00 and gave the stock an &#34;overweight&#34; rating in a research report on Friday, March 21st. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $74.75.</p>
<div class="lb-trans"><p>CVS 一直是多份研究分析報告的主題。摩根士丹利在 4 月 15 日（星期二）的報告中重申了對 CVS Health 股票的 “增持” 評級。Wall Street Zen 在 5 月 9 日（星期五）的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。Cowen 在 5 月 5 日（星期一）的研究報告中重申了對 CVS Health 股票的 “買入” 評級。Argus 在 2 月 18 日（星期二）的研究報告中設定了 CVS Health 的目標價為 77.00 美元。最後，Piper Sandler 在 3 月 21 日（星期五）的研究報告中將 CVS Health 的目標價從 72.00 美元上調至 74.00 美元，並給予該股票 “增持” 評級。有兩位研究分析師對該股票給予了 “持有” 評級，十七位給予了 “買入” 評級，一位給予了 “強烈買入” 評級。根據 MarketBeat，該股票的共識評級為 “適度買入”，共識目標價為 74.75 美元。</p>
</div><p><strong>View Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CVS 的最新報告</strong></p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房及消費者健康三個部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>What Are Treasury Bonds?</li>
<li>IBM Up 10 Days in a Row: What’s Driving the Winning Streak?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Upstart Stock’s Bull Case Just Got a Lot Stronger</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>Higher Gulf Oil Output Puts These Energy Names in Play</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 CVS Health</li>
<li>什麼是國債？</li>
<li>IBM 連續上漲 10 天：是什麼推動了這一勝利的連勝？</li>
<li>什麼是分紅收割策略，投資者如何從中獲利？</li>
<li>Upstart 股票的牛市案例剛剛變得更強大</li>
<li>揭示 VWAP 的力量：交易者的關鍵指標</li>
<li>海灣石油產量增加使這些能源公司受到關注</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒是由敍事科學技術和 MarketBeat 的金融數據生成的，旨在為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 CVS Health 並不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

五三銀行增加了其在 CVS Health 公司的股票持有量（紐約證券交易所代碼：CVS）